Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?

Journal of Substance Abuse Treatment

Volumn 38, Issue SUPPL. 1, 2010, Pages

  Nunes, Edward V ^a   Ball, Samuel ^b   Booth, Robert ^c   Brigham, Gregory ^d   Calsyn, Donald A ^e   Carroll, Kathleen ^b   Feaster, Daniel J ^f   Hien, Denise ^a,g   Hubbard, Robert L ^h   Ling, Walter ⁱ   Petry, Nancy M ^j   Rotrosen, John ^k   Selzer, Jeffrey ^a,l   Stitzer, Maxine ^m   Tross, Susan ^a   Wakim, Paul ⁿ   Winhusen, Theresa ^o   Woody, George ^p  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Maryhaven   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g CITY UNIVERSITY OF NEW YORK   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Committee for Physician Health ^*  (United States)

^m JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^o UNIVERSITY OF CINCINNATI   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Clinical trial; Design; Drug; Effectiveness; HIV

Indexed keywords

BUPRENORPHINE; CLONIDINE; METHADONE; NICOTINE;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; COGNITIVE THERAPY; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG DOSE REDUCTION; EFFECT SIZE; EVIDENCE BASED MEDICINE; EXTERNAL VALIDITY; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH PROGRAM; HIGH RISK BEHAVIOR; HIV EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNAL VALIDITY; METHODOLOGY; MOTIVATION; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATIENT COUNSELING; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RISK REDUCTION; SAFE SEX; SMOKING CESSATION; TOBACCO DEPENDENCE;

COMMUNITY HEALTH SERVICES; COMPARATIVE EFFECTIVENESS RESEARCH; EVIDENCE-BASED MEDICINE; HUMANS; INFORMATION DISSEMINATION; NATIONAL INSTITUTE ON DRUG ABUSE (U.S.); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 77950227170     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2010.01.012     Document Type: Article

References (41)

1. Amrhein P.C., Miller W.R., Yahne C.E., Palmer M., Fulcher L. Client commitment language during motivational interviewing predicts drug use outcomes. Journal of Consulting and Clinical Psychology 2003, 71:862-878.
2. Ball S.A., Martino S., Nich C., Frankforter T.L., Van Horn D., Crits-Christoph P., et al. Site matters: Multisite randomized trial of motivational enhancement therapy in community drug abuse clinics. Journal of Consulting and Clinical Psychology 2007, 75:556-567.
3. Bartholomew N.G., Simpson D.D. Time out! For men: A communication skills & sexuality workshop for men 1996, Texas Christian University, Institute of Behavioral Research, Fort Worth.
4. Brigham G.S., Feaster D.J., Wakim P.G., Dempsey C.L. Choosing a control group in effectiveness trials of behavioral drug abuse treatments. Journal of Substance Abuse Treatment 2009, 37:388-397.
5. Brown H., Prescott R. Applied mixed models in medicine 1999, John Wiley & Sons, London.
6. Calsyn D.A., Hatch-Maillette M., Tross S., Doyle S.R., Crits-Christoph P., Song Y.S., et al. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. Journal of Substance Abuse Treatment 2009, 37:138-150.
7. Campbell B.K., Fuller B.E., Lee E.S., Tillotson C., Woelfel T., Jenkins L., et al. Facilitating outpatient treatment entry following detoxification for injection drug use: A multisite test of three interventions. Psychology of Addictive Behaviors 2009, 23:260-270.
8. Carroll K.M., Ball S.A., Nich C., Martino S., Frankforter T.L., Farentinos C., et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence 2006, 81:301-312.
9. Carroll K.M., Martino S., Ball S.A., Nich C., Frankforter T., Anez L.M., et al. A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users. Journal of Consulting and Clinical Psychology 2009, 77:993-999.
10. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Erlbaum Associates, Publishers, Hillsdale, NJ. 2nd ed.
11. El-Bassel N., Schilling R.F. 15-Month followup of women methadone patients taught skills to reduce heterosexual HIV transmission. Public Health Reports 1992, 107:500-504.
12. Feaster D.J., Robbins M.S., Horigian V., Szapocznik J. Statistical issues in multisite effectiveness trials: The case of brief strategic family therapy for adolescent drug abuse treatment. Clinical Trials 2004, 1:428-439.
13. Hien D.A., Jiang H., Campbell A.N.C., Hu M., Miele G.M., Cohen L.R., et al. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. American Journal of Psychiatry 2010, 167:95-101.
14. Hien D.A., Wells E.A., Jiang H., Suarez-Morales L., Campbell A.N., Cohen L.R., et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. Journal of Consulting and Clinical Psychology 2009, 77:607-619.
15. Hubbard R.L., Leimberger J.D., Haynes L., Patkar A.A., Holter J., Liepman M.R., et al. Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: A NIDA Clinical Trials Network (CTN) study. American Journal on Addictions 2007, 16:495-502.
16. Institute of Medicine Bridging the gap between practice and research: Forging partnerships with community-based drug and alcohol treatment 1998, National Academy Press, Washington, DC.
17. Jones H.E., Svikis D., Rosado J., Tuten M., Kulstad J.L. What if they do not want treatment? Lessons learned from intervention studies of non-treatment-seeking, drug-using pregnant women. American Journal on Addictions 2004, 13:342-357.
18. Jones H.E., Svikis D.S., Tran G. Patient compliance and maternal/infant outcomes in pregnant drug-using women. Substance Use and Misuse 2002, 37:1411-1422.
19. Ling W., Amass L., Shoptaw S., Annon J.J., Hillhouse M., Babcock D., et al. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 2005, 100:1090-1100.
20. Ling W., Hillhouse M., Domier C., Doraimani G., Hunter J., Thomas C., et al. Buprenorphine tapering schedule and illicit opioid use. Addiction 2009, 104:256-265.
21. Mikulich S.K., Zerbe G.O., Feaster D.J. Some ramifications of treating "site" as random in multi-center clinical trials. Controlled Clinical Trials 2003, 24:43S-2405.
22. Miller W.M., Rollnick S. Motivational interviewing: Preparing people for change 2002, Guilford Press, New York. 2nd ed.
23. Miller W.R., Manuel J.K. How large must a treatment effect be before it matters to practitioners? An estimation method and demonstration. Drug and Alcohol Review 2008, 27:524-528.
24. Miller W.R., Mount K.A. A small study of training in motivational interviewing. Does one workshop change clinician and patient behavior?. Behavioural and Cognitive Psychotherapy 2001, 29:457-471.
25. The NIMH Multisite HIV Prevention Trial: Reducing HIV sexual risk behavior. Science 1998, 280:1889-1894. National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group.
26. Olmstead T.A., Sindelar J.L., Petry N.M. Clinic variation in the cost-effectiveness of contingency management. Am J Addict 2007, 16:457-460.
27. Peirce J.M., Petry N.M., Stitzer M.L., Blaine J., Kellogg S., Satterfield F., et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry 2006, 63:201-208.
28. Petry N.M. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug and Alcohol Dependence 2000, 58:9-25.
29. Petry N.M., Alessi S.M., Marx J., Austin M., Tardif M. Vouchers versus prizes: Contingency management for treatment of substance abusers in community settings. Journal of Consulting and Clinical Psychology 2005, 73:1005-1014.
30. Petry N.M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. Journal of Consulting and Clinical Psychology 2002, 70:398-405.
31. Petry N.M., Peirce J.M., Stitzer M.L., Blaine J., Roll J.M., Cohen A., et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment clinical trials network study. Archives of General Psychiatry 2005, 62:1148-1156.
32. Petry N.M., Tedford J., Autsin M., Nich C., Carroll K.M., Rounsaville B.J. Prize reinforcement contingency management for treatment of cocaine abusers: How low can we go, and with whom?. Addiction 2004, 99:349-360.
33. Raudenbush S.W., Liu X. Statistical power and optimal design for multisite randomized trials. Psychological Methods 2000, 5:199-213.
34. Reid M.S., Fallon B., Sonne S., Flammino F., Nunes E.V., Jiang H., et al. Smoking cessation treatment in community-based substance abuse rehabilitation programs. Journal of Substance Abuse Treatment 2008, 35:68-77.
35. Robbins M.S., Szapocznik J., Horigian V.E., Feaster D.J., Puccinelli M., Jacobs P., et al. Brief strategic family therapy for adolescent drug abusers: A multi-site effectiveness study. Contemporary Clinical Trials 2009, 30:269-278.
36. Rounsaville B.J., Carroll K.M., Onken L.S. NIDA's stage model of behavioral therapies research: Getting started and moving on from Stage I. Clinical Psychology: Science and Practice 2001, 8:133-142.
37. Shoptaw S., Tross S., Stephens M., Tai B. A snapshot of HIV/AIDS-related services in the clinical treatment providers for NIDA's clinical trials network. Drug and Alcohol Dependence 2002, 66:S163. & NIDA CTN HIV/AIDS Workgroup.
38. Sindelar J.L., Olmstead T.A., Peirce J.M. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs. Addiction 2007, 102:1463-1471.
39. Tross S., Campbell A.N., Cohen L.R., Calsyn D., Pavlicova M., Miele G.M., et al. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of NIDA Clinical Trials Network Trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 2008, 48:581-589.
40. Winhusen T., Kropp F., Babcock D., Hague D., Erickson S.J., Renz C., et al. Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users. Journal of Substance Abuse Treatment 2008, 35:161-173.
41. Woody G.E., Poole S.A., Subramaniam G., Dugosh K., Bogenschutz M., Abbott P., et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: A randomized trial. Journal of the American Medical Association 2008, 300:2003-2011.